The therapeutic revolution in therapy for hepatitis
C virus (HCV) seen in recent years has left some crucial gaps, with
genotypes other than genotype 1 having either less evidence of efficacy
or proven lower efficacy. Even with the potential availability of drugs
with cure rates approaching 100%, it is uncertain how many populations
across the world will have the finance and the health system
organisation to access these therapies.1
Please visit SoulofHealing.org, non profit, 501(c)(3) for our patient assistance programs. If you have been denied by insurance or you do not have insurance please visit SunnyPharma.info to get generic Sovaldi($695), Harvoni($1495), Epclusa($2195) and Daklinza($695). All prices are based upon 12 weeks and 84 tablets. Verified by American doctors and nurses.
No comments:
Post a Comment